Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
University of Illinois at Chi
Search grants from University of Illinois at Chi
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Improving the molecular diagnosis of drug resistant tuberculosis
Expanding the druggable genome
HIV Reservior &CD4 Repopulation in Gut lymphoid tissue
Preventive Medicine Residency Training
A Comprehensive Residential Drug Prevtn & Treatmnt Prgrm
Recently added grants:
Neuroscientific Exploration of Cultural Protective Factors in American Indians
Passive mobile sensing and machine learning for the detection of drinking episodes
Resolving differences between clinical opioids at single neurons
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosis
Credentialing Delta-like 3 (DLL3) as an oncoprotein and immunotherapeutic target in neuroblastoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN985081-003
Application #
7191436
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chi
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
NIH 2004
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
Comments
Be the first to comment on this grant